Statistics

Total Visits

Views
Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancer35

Select a period of time:

Number of views in the range

Views
Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancer1

Views

Views
June 20250
July 20251
August 20250
September 20250
October 20250
November 20250
December 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States1
 

Top cities views

Views
Harlingen1